Because rates of EPS and TDs may exceed 50% among older patients, many experts encourage clinicians to taper antipsychotic dosages in patients with stable chronic symptoms. Tapering dosages may be critically important because EPS may affect functional performance more than positive or negative symptoms or duration of psychoses.